Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMAT: Adjuvant Sunitinib After Resection of Pulmonary Metastases in Renal Cell Carcinoma
NCT01216371Phase 2Terminated
- Sponsor
- Society of Urologic Oncology
- Start
- Oct 2010
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Society of Urologic Oncology. Started Oct 2010; status: terminated.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01216371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216371.